Evidence map›Paper›PMID 26227618›Full record

ReviewClinical neuroradiology2015

Hybrid MR-PET in Neuroimaging.

S Bisdas, C Lá Fougere, U Ernemann

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical neuroradiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S BisdasDepartment of Diagnostic and Interventional Neuroradiology, Eberhard Karls University Hospital, Hoppe-Seyler Str. 3, 72076, Tübingen, Germany. sotirios.bisdas@uni-tuebingen.de.
C Lá FougereDepartment of Nuclear Medicine and Molecular Imaging, Eberhard Karls University Hospital, Tübingen, Germany.
U ErnemannDepartment of Diagnostic and Interventional Neuroradiology, Eberhard Karls University Hospital, Hoppe-Seyler Str. 3, 72076, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hybrid magnetic resonance (MR)-positron emission tomography (MR-PET) is a novel technology with advantages over sequential MR and PET imaging, allowing maintain full individual diagnostic performance with negligible mutual interference between the two hardware settings. Obvious synergies between MR and PET in acquisition of anatomical, functional, and molecular information for neurological diseases into one single image pave the way for establishing clear clinical indications for hybrid MR-PET as well as addressing unmet neuroimaging needs in future clinics and research. Further developments in attenuation correction, quantification, workflow, and effective MR-PET data management might unfold the full potential of integrated multimodality imaging.

Indexed as

Brain DiseasesFluorodeoxyglucose F18HumansImage EnhancementMagnetic Resonance ImagingMolecular ImagingMultimodal ImagingPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsBrain tumorsDementia imagingEpilepsy imagingHybrid imagingMR-PET

Identifiers

PMID26227618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.